aCROmion
aCROmion is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
GUIDANCE – A multicenter phase II trial of maintenance durvalumab and olaparib after standard 1st-line treatment (carboplatin/cisplatin, etoposide, durvalumab) in HRD-positive extensive-disease small-cell lung cancer
Sponsor University Of Cologne
- Start (EU)
- Latest update
- Estimated end
- Not reported
Phase IIa randomized, double-blind, and placebo-controlled multicenter split body trial to determine safety, tolerability, and efficacy of repeated doses of ACOU085 for the prevention of hearing loss in testicular cancer patients receiving cisplatin
Sponsor Acousia Therapeutics GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 3b, Randomized, Double-blind, Parallel Group, Multicenter Study to Evaluate Further Therapeutic Strategies with Guselkumab in Patients with Moderate-to-Severe Plaque-Type Psoriasis
Sponsor Janssen Cilag International
- Start (EU)
- Latest update
- Estimated end
- Not reported
HD21 for advanced stages - Treatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphoma; comparison of 4-6 cycles of escalated BEACOPP with 4-6 cycles of BrECADD
Sponsor University Of Cologne
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for aCROmion?
The 2026-10-09 snapshot links aCROmion to 4 distinct CTIS trials. Recorded services include Clinical monitoring, Data management, Electronic data capture, Medical writing, among 9 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for aCROmion?
The most frequently recorded therapeutic areas are Respiratory, Solid Tumor Oncology. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to aCROmion conducted?
The linked trials record locations in 6 countries, including Germany, Austria, Denmark, Netherlands, Norway. These are trial locations, not confirmed office locations or countries where aCROmion delivered services.
What can this page tell me about aCROmion's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 2 recorded name variants under aCROmion. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Acromion GmbH
- aCROmion GmbH